Papers
1
Total Citations
62
H-Index
1
About
Dr. Hak Ju Kim is a leading urologic oncologist whose research focuses on optimizing surgical outcomes for upper-tract urothelial carcinoma (UTUC). His major contributions center on comparative effectiveness research, systematically evaluating open, laparoscopic, and robotic nephroureterectomy approaches to determine the safest and most oncologically effective techniques. His landmark 2019 study, cited over 60 times, provided critical evidence by analyzing perioperative and oncological outcomes across 422 patients, helping to guide surgical decision-making for non-metastatic UTUC. Dr. Kim’s work has significantly advanced the field of minimally invasive urologic surgery, demonstrating that robotic and laparoscopic approaches can achieve comparable cancer control to open surgery while potentially reducing recovery times and complications. His research is widely referenced by surgeons seeking evidence-based comparisons of surgical modalities. Through rigorous retrospective analyses and outcome-driven methodology, Dr. Kim has established himself as an authority in urologic oncology, particularly in refining surgical strategies that balance oncologic efficacy with patient quality of life. His contributions continue to shape clinical guidelines and surgical practice for upper-tract urothelial carcinoma.
Research Focus
Key Achievements
Top Papers
- 1